Breaking News

Brammer Bio Formed Through Merger

Brammer Biopharmaceuticals and Florida Biologix join forces to create leading cell and gene therapy CDMO

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Brammer Biopharmaceuticals has merged with Florida Biologix to create a cell and gene therapy biologics contract development and manufacturing organization (CDMO). The merged company, Brammer Bio, will combine technical expertise in process development and clinical manufacturing with capabilities, operating approaches and quality standards required for commercial manufacturing. Brammer Bio is focused on providing clinical and commercial supply of autologous and allogeneic cell therapies, and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters